Albany Molecular Research... (AMRI)
NASDAQ: AMRI
· Real-Time Price · USD
21.74
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
Albany Molecular Research Revenue Breakdown
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Active Pharmaceutical Ingredients Revenue | 1.58M | 2.77M | 1.06M | 4.35M | 2.74M | 3.38M | 3.29M | 2.54M | 2.45M | 2.39M | n/a | n/a | 5.07M | n/a | n/a | 11.14M | 6.71M | 6.82M |
| Active Pharmaceutical Ingredients Revenue Growth | -42.86% | +161.59% | -75.72% | +58.81% | -18.91% | +2.61% | +29.94% | +3.51% | +2.60% | n/a | n/a | -100.00% | n/a | n/a | -100.00% | +66.09% | -1.60% | n/a |
| Corporate Segment Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.24M | 5.97M | n/a | 5.71M | 5.7M | n/a | n/a | n/a |
| Corporate Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -29.05% | n/a | n/a | +0.21% | n/a | n/a | n/a | n/a |
| Discovery Drug Development And Small Scale Manufacturing Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -63K | 1.79M | n/a | 2.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Discovery Drug Development And Small Scale Manufacturing Revenue Growth | n/a | n/a | n/a | n/a | n/a | -100.00% | -103.53% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Drug Product Manufacturing Revenue | 632K | 832K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Drug Product Manufacturing Revenue Growth | -24.04% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Fine Chemicals Revenue | n/a | n/a | 9.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Fine Chemicals Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 38.65M | 33.43M | 32.31M | 37.3M | 27.93M | 24.6M | 22.18M | 21.22M | 16.52M | 17.47M |
| Selling, General, and Administrative Revenue Growth | +15.60% | +3.47% | -13.39% | +33.58% | +13.52% | +10.90% | +4.54% | +28.46% | -5.47% | n/a |
| Research and Development Revenue | 3.46M | 3.37M | 4.76M | 4.64M | 3.48M | 3.17M | 2.7M | 1.9M | 385K | 490K |
| Research and Development Revenue Growth | +2.61% | -29.07% | +2.48% | +33.43% | +9.82% | +17.51% | +41.67% | +394.29% | -21.43% | n/a |